Periodic Reporting for period 4 - PNANOMED (Personalized Nanomedicines for Leukemia Patients)

Acute myeloid leukemia (AML) is a heterogeneous clonal disorder affecting myeloid hematopoiesis, caused by accumulation of genetic aberrations that result in increased self-renewal and proliferation, a block in differentiation, and reduced apoptosis. Although the majority of...